Paper

972 Risk for immune-related adverse events following immune checkpoint blockade is linked to a RORA regulatory variant

Journal for ImmunoTherapy of Cancer · 2026 · F.X. Danlos, Lydie Cassard, Tatiana Traboulsi et al.